Skip to main content

Table 3 Results of ATRX expression status stratified by tumor location

From: ATRX immunostaining predicts IDH and H3F3A status in gliomas

Tumor location ATRX loss/retention (%) ATRX loss/retention (n)
Frontal lobe 48/29 79/27
Parietal lobe 7/9 12/44
Temporal lobe 26/30 43/139
Occipital lobe 2/4 4/20
Thalamus 1/2 1/8
Intraventricular 1/2 1/10
Brainstem and midbrain 1/2 1/11
Cerebellum 1/5 2/24
Spinal cord 1/10 1/49
Multiple locations 13/6 21/27